Day	Time	Speaker Name	Talk Title
1	10:00 - 10:20	Bérénice Hansen	Fasting leads to disease activity suppression and sustained weight loss in rheumatoid arthritis
	10:20 - 10:40	Jeff Didier	Sex-specific Classification of Frailty Outperforms Mixed Models and Reveals Underlying Differences In Their Frailty Profiles – Data from the Berlin Aging Study II (BASE-II)
	15:00 - 15:20	Dominika Klimek	Planctomycetota from anaerobic digesters: phylogenetic diversity and hidden carbohydrolytic potential
	15:20 - 15:40	Candy Steffen	A protein-interface disrupting 23-mer peptide is a prototypic H-Ras- nanocluster and -signalling disruptor
2	10:00 - 10:20	Andrea Scafidi	Exploring peripheral immune cell adapatation and inter individual differences in glioblastoma
	10:20 - 10:40	Hanane Baidarjad	NEIL3 modulates the expression of telomere shelterin complex in glioblastoma cell lines to maintain telomere integrity
	10:40 - 11:00	Agnieszka Demczuk	Cytometry Cluster Annotation and Differential Abundance Suite (Cycadas): Enabling efficient and reproducible analysis of clustered cytometry data
	15:00 - 15:20	Frida Lind-Holm Mogensen	PARK7/DJ-1 deficiency affects microglial activation making microglia hypo-responsive during inflammation
	15:20 - 15:40	Anne-Marie Hanff	Progression of Parkinson’s disease in women and men. A longitudinal mixed-models analysis of the Luxembourg Parkinson’s study

Poster #	Name	Title	Title
1	Elisa Zuccoli	Investigating α-synuclein aggregation in patient-specific immunocompetent midbrain organoids in Parkinson’sdisease.
2	Júlia OrtísSunyer	Alterations in Microbiome-borne Flagella in Parkinson’s Disease and Idiopathic Rapid-Eye-Movement SleepBehavior Disorder
3	Christiane Oleksy	Studying digenic Parkinson’s disease in a stem cell model carrying mutant p.N409S in the GBA1 gene and the homozygous deletion of exon 3 PARK2
4	Rebecca Loo Ting Jiin	Predictive Machine Learning Models of Levodopa-Induced Dyskinesia Prognosis in Parkinson’s Disease Across Cohorts
5	Zahraa Berro	A correlative approach for the investigation of metal accumulation in the human brain using different high resolution and high sensitivity SIMS imaging techniques
6	Marijus Giraitis	DIGITAL SUPPORT FOR SELF-MANAGEMENT AND HEALTH LITERACY IN PARKINSON’S DISEASE
7	Mónica Miranda de la Maza	Impact of the interplay between astrocytes, microglia and infiltrate immune cells under inflammatory conditions in Alzheimer’s disease.
8	Sophie Schreiner	Identification of Neuroprotecive Pathways to Improve therapy of Age-related neurodegeneraive diseases
9	Félicia Jeannelle	DYNAMIC CONTROL OF ASTROCYTE SIGNATURES BY NORADRENALINE AND ITS IMPACT ON ALZHEIMER’S DISEASE
10	Chloe Duculty	Targeting the One-carbon Metabolism: a Novel Therapeutic Strategy in CLL
11	Daniela Maria Vega Gutierrez	Influence of Metabolically-Rewired Calcium Signaling in Melanoma on the Immune response
12	Elisabetta Bartolini	Impact of targeting autophagy on the expression of proinflammatory chemokines in neuroblastoma cells
13	Hugo Bonnemain Pascual	Role of chemokine receptor-bearing extracellular vesicles in leukaemia and lymphoma
14	Tiantian YI	Elucidation of the XAB2-dependent and -independent mechanisms promoting Ku eviction from seDSB ends and the HR repair of single-ended DSBs and their relevance to chemotherapy
15	Tourneur Lucas	Roles of the epigenetic reader of DNA methylation MBD1 in IDH-mutated gliomas
16	Vanessa Klapp	Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukemia
17	Jeanne Le Cléac’h	Diving into epigenetics analysis to understand the adversity immunophenotype while excluding genetic effects: The ImmunoTwin cohort
18	Ana-Alonso-Bartolome	NanoLux resource platform: Nanoluciferase-based sensors and assays to illuminate the role of ubiquitin in signalling, trafficking and pharmacology of GPCRs
19	Ester Cassano	Unravelling the pharmacological proper1es of LIH383 and its binding mode to ACKR3
20	Hélène De Franco	Building gut microbiome metabolic models for food response prediction